Cognitive Behavioral Therapy for Mental Health Issues in Youth
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a special therapy called the Unified Protocol, designed to help children and teens manage emotional issues like anxiety or depression. Researchers aim to assess the therapy's effectiveness through interviews and questionnaires. The trial divides participants into two groups: one for kids and one for teens, with both groups involving parents to help manage strong emotions. It suits kids and teens, ages 7-17, living in Miami-Dade County, who experience anxiety, depression, trauma, or similar emotional challenges. As an unphased trial, it offers participants a unique opportunity to contribute to the development of innovative therapies for emotional challenges.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications. It seems likely that you can continue your current medications, but it's best to confirm with the trial organizers.
What prior data suggests that these cognitive-behavioral therapies are safe for youth?
Research shows that both the Unified Protocol for Adolescents (UP-A) and the Unified Protocol for Children (UP-C) are well-tolerated treatments. For teenagers, several studies, including those with random assignments, have found that the UP-A helps manage emotional issues without causing major side effects. This indicates the treatment is safe for teens, with no serious safety problems reported.
Similarly, the UP-C, designed for children, has been used in various places, such as Japan, and has shown promise as a type of Cognitive Behavioral Therapy (CBT) applicable to different issues. It focuses on group sessions with both children and their caregivers. No major reports of harm have emerged, indicating it is well-tolerated.
Both treatments use strategies to help manage emotions, which are key to the therapy. The evidence so far supports the safety of these protocols, making them a reliable option for treating emotional disorders in young people.12345Why are researchers excited about this trial?
Researchers are excited about these treatments because the Unified Protocols (UP-A and UP-C) offer a flexible, one-size-fits-all approach to treating a range of emotional disorders in young people, unlike traditional therapies that tend to target specific disorders individually. These protocols focus on teaching adolescents and children, along with their parents, strategies to handle intense emotions, which can be beneficial across various mental health challenges. Moreover, the group format of the UP-C also fosters social support, which can enhance treatment outcomes for children. This transdiagnostic method is gaining attention as it could streamline therapy processes and make emotional care more accessible and comprehensive for youth.
What evidence suggests that these treatments could be effective for emotional disorders in youth?
Research has shown that the Unified Protocol for Adolescents (UP-A), which participants in this trial may receive, effectively helps young people with emotional issues. Studies have found that it significantly reduces symptoms of anxiety and depression. Similarly, the Unified Protocol for Children (UP-C), another treatment option in this trial, has successfully eased anxiety and depression in children, yielding strong results. Both children's self-reports and their parents' reports indicate significant improvement in anxiety symptoms. Overall, these treatments help children and adolescents manage strong emotions better.12678
Who Is on the Research Team?
Jill Ehrenreich-May, PhD
Principal Investigator
University of Miami
Are You a Good Fit for This Trial?
This trial is for children aged 7-17 with anxiety, depression, or similar emotional disorders who live in Miami-Dade County. They must speak English/Spanish and have a parent to participate in all sessions. Excluded are those prioritizing other issues like eating disorders or substance abuse, or who've had psychiatric hospitalization recently.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the Unified Protocols for Transdiagnostic Treatment of Emotional Disorders in Children (UP-C) and Adolescents (UP-A) for up to 24 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- The Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders in Adolescents
- The Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders in Children
Trial Overview
The study tests the Unified Protocols for Transdiagnostic Treatment of Emotional Disorders in Children (UP-C) and Adolescents (UP-A). These cognitive-behavioral therapies aim to treat various emotional disorders through standardized measures and interviews.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
The participants in this group will receive the Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders in Children (UP-C) in up to 15 sessions through a group format, attended over up to 24 weeks. Sessions will include parent and child strategies to manage strong emotions.
The participants in this group will receive the Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders in Adolescents (UP-A) in an individual format for up to 24 weeks.
The Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders in Adolescents is already approved in United States for the following indications:
- Anxiety disorders
- Depressive disorders
- Obsessive-compulsive disorder
- Other emotional disorders
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Miami
Lead Sponsor
The Children's Trust, Miami FL
Collaborator
The Children's Trust
Collaborator
Published Research Related to This Trial
Citations
Efficacy of unified protocol for transdiagnostic treatment ...
This study is a two-armed, randomised controlled trial on the efficacy of 12 week UP-A on adolescents with emotional disorders along with their parents.
2.
advancesinpsychiatryandbehavioralhealth.com
advancesinpsychiatryandbehavioralhealth.com/article/S2667-3827(25)00008-0/abstractUnified Protocols for Transdiagnostic Treatment of Emotional ...
Unified protocol for the transdiagnostic treatment of emotional disorders: protocol development and initial outcome data. Cogn Behav Pract ...
The efficacy of the unified protocol for emotional disorders ...
Overall, our findings suggest that the UP-C/A is effective in treating internalizing symptoms in children and adolescents that can be offered in different ...
Unified Protocol for the Transdiagnostic Treatment of ...
The aim of this systematic review is to know the current (research studies) and future research interest (study protocols) in using the UP for ...
Feasibility, Acceptability, and Preliminary Efficacy of the ...
The effectiveness of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Children and Adolescents (UP-C/A; Ehrenreich-May et al., 2018) ...
Unified Protocol for Transdiagnostic Treatment of ...
A comprehensive CBT-based workbook offering strategies to help adolescents manage various emotional disorders through emotion-focused education, awareness ...
The Unified Protocol for Transdiagnostic Treatment of ...
We introduced the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Children (UP-C) in Japan and adapted it to the Japanese context.
An Iteratively Adapted Transdiagnostic Prevention Program ...
The UP-A has been found to effectively treat adolescent emotional disorders in multiple studies, including randomized controlled trials (RCTs) [ ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.